The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Factors influencing withdrawal without a defined reason in oncology trials.
 
Rodrigo Paredes
No Relationships to Disclose
 
Alexander Karol
No Relationships to Disclose
 
Anna Argulian
No Relationships to Disclose
 
Kasopefoluwa Oguntuyo
No Relationships to Disclose
 
Lexi Weintraub
No Relationships to Disclose
 
Justin Miller
Employment - Merck
 
Yu Fujiwara
Travel, Accommodations, Expenses - Conquer Cancer, the ASCO Foundation
 
Himanshu Joshi
No Relationships to Disclose
 
Deborah Doroshow
Honoraria - MJH Life Sciences
Consulting or Advisory Role - AstraZeneca; Atheneum; Boehringer Ingelheim; Dedham Group; G1 Therapeutics; MJH Life Sciences; Sanofi; Sonata Therapeutics; Summit Therapeutics; Takeda
Travel, Accommodations, Expenses - Boehringer Ingelheim; MJH Life Sciences
Other Relationship - Bristol Myers Squibb Foundation; Conquer Cancer Foundation
 
Matthew Galsky
Consulting or Advisory Role - Abbvie; AstraZeneca; Bicycle Therapeutics; Bristol-Myers Squibb; Curis; Daiichi Sankyo Europe GmbH; EMD Serono; Gilead Sciences; Janssen; Merck; Pfizer; Seagen
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - METHODS AND COMPOSITIONS FOR TREATING CANCER AND RELATED METHODS. MOUNT SINAI SCHOOL OF MEDICINE July 2012 Application number: 20120322792